KalVista Pharmaceuticals, Inc. ($KALV)
Piekos Brian โ Chief Financial Officer
Shares
1,489
Price
$26.78
Total Value
$39,881.97
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Piekos Brian |
|---|---|
| Title | Chief Financial Officer |
| Transaction Date | May 22, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | May 26, 2026 |
| Shares Sold | 1,489 |
| Price per Share | $26.78 |
| Total Value | $39,881.97 |
| Shares Owned After | 21,661 |
| Derivative | No |
| Accession Number | 0001815308-26-000004 |
| Document | View SEC Filing |